ProShares Short S&P500

SH

The company does not have a clearly defined business or industry classification.
Its identity and core characteristics cannot be determined from the available information.

$36.14 +0.10 (+0.28%)

Updated: February 19, 2026, 16:00 EST

Analyzed by Rockflow Bobby Quantitative Model ✓ Updated Daily

Investment Opinion: Should I buy SH Today?

Based on the available information, SH presents a highly specialized and risky profile that is unsuitable for most long-term investors. The fund acts as an inverse ETF, designed to gain value when the market declines, as confirmed by its negative beta. While it may appear oversold from a technical perspective, this is a direct result of its inherent strategy.

Crucially, the absence of fundamental and valuation data makes any assessment of its intrinsic worth impossible. It cannot be analyzed as a traditional company with revenue or earnings. Its performance is purely a function of market direction and the mechanics of its inverse structure, which carry significant risks like daily reset compounding.

Recommendation: Strong Sell / Avoid for Long-Term Holding.

Investors should avoid SH for long-term portfolios. It is a tactical trading instrument for sophisticated investors seeking to hedge or bet against the market over very short periods. For the vast majority of investors seeking capital appreciation, its high-risk, speculative nature and lack of fundamental value make it an inappropriate and dangerous buy-and-hold investment.

*This is not investment advice, for reference only.*

CTA Banner

SH 12-Month Price Forecast

RockFlow Model Forecast: Three Scenarios for 2026

Based on the analysis provided, the 12-month outlook for SH is profoundly negative for a long-term investor.

The primary catalyst for any price increase would be a significant and sustained downturn in the S&P 500, as the fund is designed to move inversely to the index. However, the major risk is its structural design, including daily reset compounding, which can cause significant erosion of value over time, especially in volatile or rising markets, making it highly unsuitable for a 12-month holding period. Given its lack of intrinsic value and the risk of long-term market appreciation, any engagement should be viewed as a speculative, short-term trade rather than a long-term investment. Consequently, a target price is not applicable or meaningful for this instrument over a 12-month horizon.

*Disclaimer: This analysis is for informational purposes only and does not constitute investment advice.*

Wall Street Consensus

Most Wall Street analysts are optimistic about ProShares Short S&P500's 12-month outlook, with consensus target around $36.14, indicating expected upside potential.

Average Target
$36.14
0 analysts
Implied Upside
+0%
vs. current price
Analyst Count
0
covering this stock
Price Range
$29 - $47
Analyst target range
Buy Buy
0 (0%)
Hold Hold
0 (0%)
Sell Sell
0 (0%)

Bulls vs Bears: SH Investment Factors

Overall, SH has investment potential but also faces challenges. Here are key factors to weigh before investing.

Bullish Bullish
  • Multiple IPO filings: Guident and Medikra planning IPOs showing market optimism for new listings.
  • Successful private placement: DarioHealth raising $17.5M via private placement demonstrates investor interest.
  • Major buyback program: News Corporation announcing $1 billion stock buyback supports share price.
  • Stock Connect inclusion: WOER added to SH-/SZ-HK Stock Connect broadening investor base.
Bearish Bearish
  • Negative analyst outlook: Citi initiates 90-day negative watch on CPIC expecting weak FY25 results.
  • Market delisting planned: Tornado Infrastructure planning TSX-V delisting indicates corporate restructuring uncertainty.
  • Execution risk on IPOs: Multiple planned IPOs carry pricing and market reception risks.
Reward Banner

SH Technical Analysis

SH has exhibited defensive characteristics through minimal recent price changes despite significant volatility over the past year.

The stock has shown relative stability over the past month with a modest 1.8% gain, though underperforming the broader market slightly over three months with a -0.17% relative return. The negative beta of -0.96 confirms its defensive nature, tending to move inversely to market direction. Currently trading at $36.22, the stock sits just 2.5% above its 52-week low and approximately 29.5% below its 52-week high, indicating it remains near the lower end of its annual range. Given the substantial distance from its yearly peak and proximity to recent lows, the stock appears oversold rather than overbought.

📊 Beta
-0.96
-0.96x market volatility
📉 Max Drawdown
-29.1%
Largest decline past year
📈 52-Week Range
$35-$51
Price range past year
💹 Annual Return
-11.9%
Cumulative gain past year
Period SH Return S&P 500
1m -0.6% +1.0%
3m -2.0% +1.9%
6m -6.0% +6.5%
1y -11.9% +12.1%
ytd +0.4% +0.2%

SH Fundamental Analysis

Of course. Since no specific financial data is available for SH, the analysis will outline the framework and key areas a professional would examine once data is obtained.

Analysis of SH's Fundamentals (Based on Available Data)

1. Revenue & Profitability Without current revenue or profitability figures, an assessment cannot be made. A professional analysis would focus on the trends in top-line revenue growth (quarterly and annually) and the trajectory of net profit margins. This would determine if the company is expanding its market share and effectively converting sales into actual earnings, or if it is facing pricing pressures or rising costs that are squeezing profitability.

2. Financial Health In the absence of debt ratio and cash flow statements, the company's financial health remains unquantified. A crucial analysis would center on the debt-to-equity ratio to gauge leverage and risk, and the strength of operating cash flow to ensure the company can comfortably meet its obligations and fund operations without relying on external financing. The absence of this data is a significant informational gap.

3. Operational Efficiency Key metrics for operational efficiency, such as Return on Equity (ROE) and asset turnover, are unavailable. A proper evaluation would use ROE to measure how effectively management is generating returns from shareholders' investments, while asset turnover would reveal how efficiently the company is using its asset base to generate sales. The lack of data prevents any conclusion on management's operational effectiveness.

Quarterly Revenue
N/A
Latest Quarter
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A%
Latest Quarter
Free Cash Flow
N/A
Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

RockFlow Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

Try Now & Get Tesla Stock Reward

Valuation Analysis: Is SH Overvalued?

Based on the valuation metrics provided, SH's valuation analysis cannot be meaningfully assessed as all key multiples (PE, PB, PEG, and EV/EBITDA) are unavailable. Without these fundamental data points, it is impossible to determine whether the stock is overvalued or undervalued relative to its intrinsic financial performance. A comprehensive analysis would require access to earnings, book value, and cash flow figures currently not presented.

Furthermore, a peer comparison cannot be conducted due to the absence of industry average data. Without benchmark metrics for the relevant sector, it is not possible to contextualize SH's valuation against its competitors or the broader market. For a conclusive valuation opinion, obtaining both the company's financial ratios and corresponding industry comps would be essential.

PE
N/Ax
TTM
vs. Historical
N/A
vs. Industry Avg
N/A
Industry PE ~N/A×
EV/EBITDA
N/Ax
Enterprise Value Multiple

Investment Risk Disclosure

Volatility Risk

SH exhibits significant volatility risk, evidenced by a strongly negative beta of -0.96 and a substantial 1-year maximum drawdown of -29.11%. The negative beta indicates the fund's price tends to move inversely to the broader market, which can lead to heightened volatility and unpredictable returns, especially during market rallies. The deep maximum drawdown further underscores the potential for severe capital erosion during adverse periods, emphasizing its high-risk profile for investors seeking stability.

Other Risks

While the absence of reported short interest reduces the immediate risk of a short squeeze, the primary concern lies in its inherent strategy as an inverse ETF. This structure introduces daily reset risk and compounding effects, which can cause performance to deviate significantly from the target index over longer periods. Additionally, liquidity risk may be a factor depending on average trading volume, potentially leading to wider bid-ask spreads and challenging execution prices during volatile market conditions.

FAQs

Is SH a good stock to buy?

Opinion: Neutral to cautiously bearish

SH appears oversold technically but carries significant risks as an inverse ETF, compounded by the complete lack of fundamental data needed for proper valuation. Its negative beta makes it a tactical hedge against market downturns rather than a core holding. This stock may suit only sophisticated, short-term traders who understand inverse ETF risks and can tolerate high volatility - it's unsuitable for long-term or fundamental investors given the data gaps.

Is SH stock overvalued or undervalued?

Based on the available information, SH stock cannot be classified as overvalued or undervalued. A meaningful judgment is impossible because all key valuation metrics—such as the PE, PB, and PS ratios—are unavailable. Without these fundamental data points, it is not possible to compare SH's valuation to industry averages or assess its standing relative to growth expectations or profitability. A conclusive analysis requires access to the company's financial statements to calculate these essential ratios.

What are the main risks of holding SH?

Based on the information provided about SH (ProShares Short S&P500 ETF), here are the key risks of holding this investment, ordered by importance:

1. Compounding and Tracking Error Risk: As an inverse ETF that resets daily, the fund's long-term performance will almost certainly deviate from the inverse of the S&P 500's long-term performance due to compounding effects, especially in volatile markets. 2. Market Timing Risk: The fund's negative beta means its value is designed to decrease during market rallies, creating substantial risk of capital erosion if the broader market trends upward over an extended period. 3. Liquidity and Execution Risk: Depending on trading volume, the ETF may potentially suffer from wider bid-ask spreads, leading to unfavorable execution prices and higher trading costs, particularly during periods of high market volatility.

What is the price forecast for SH in 2026?

Based on its structure as an inverse ETF tracking the S&P 500, forecasting a specific target price for SH in 2026 is not meaningful or applicable. The fund's value is purely a function of the S&P 500's performance and its inherent daily compounding mechanism.

Key Growth Driver & Main Assumption: The sole driver for SH's appreciation would be a significant, sustained bear market in the S&P 500; this forecast assumes that US equities will experience a major correction or enter a prolonged downturn by 2026.

Uncertainty: This forecast carries extreme uncertainty, as it contradicts the long-term historical upward trend of the stock market. The primary risk is that continued market growth would cause substantial erosion of SH's value due to its daily reset structure, making any long-term price target highly speculative and unreliable.